- Patent Title: Methods of using PVT1 exon 9 to diagnose and treat prostate cancer
-
Application No.: US15829263Application Date: 2017-12-01
-
Publication No.: US10344283B2Publication Date: 2019-07-09
- Inventor: Olorunseun O. Ogunwobi , Adeodat Ilboudo , Chunxiao Ying
- Applicant: Research Foundation of the City University of New York
- Applicant Address: US NY New York
- Assignee: Research Foundation of the City University of New York
- Current Assignee: Research Foundation of the City University of New York
- Current Assignee Address: US NY New York
- Agency: Schmeiser, Olsen & Watts, LLP
- Agent Peter J. Mikesell
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12N15/113 ; C12Q1/686 ; C12Q1/6886
Abstract:
PVT1 exon 9 is overexpressed in aggressively tumorigenic prostate cancer cell lines and prostate tumor tissues. This exon provides a diagnostic tool for the detection and monitoring of aggressive prostate cancer. Several small interfering ribonucleic acids (siRNAs) are disclosed that are useful for treating prostate cancer.
Public/Granted literature
- US20180080027A1 METHODS OF USING PVT1 EXON 9 TO DIAGNOSE AND TREAT PROSTATE CANCER Public/Granted day:2018-03-22
Information query
